ArticleClinical drug investigation2021

Response to "Comment on: Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety".

Young R LeePubMed ↗Publisher ↗

No numbers read from the abstract.